Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eisai
Eisai
Eisai fires back at G-BA rebuff of Fycompa
Fierce Pharma
Fri, 03/8/13 - 11:18 am
Eisai
Fycompa
epilepsy
When Will This Obesity Drug Launch?
Motley Fool
Tue, 03/5/13 - 10:43 am
obesity
Arena Pharmaceuticals
drug launches
Belviq
Eisai
A Drug That's Ready to Lose
Motley Fool
Thu, 02/28/13 - 11:30 am
Belviq
Arena Pharmaceuticals
Vivus
Eisai
Will There Ever Be an Obesity Drug Blockbuster?
Motley Fool
Sun, 02/17/13 - 12:02 pm
obesity
weight loss
Arena Pharmaceuticals
Eisai
Belviq
Qsymia
Orexigen
Eisai gets orphan drug status for Lenvatinib
Marketwatch
Fri, 02/15/13 - 11:09 am
Eisai
orphan drugs
Lenvatinib
thyroid cancer
13 Biotech Stock Predictions for 2013
TheStreet.com
Wed, 01/2/13 - 12:18 pm
Eisai
Sarepta
Arena Pharmaceuticals
Amarin
Gilead
Biomarin
Onyx
Medivation
Achillion
Incyte
Cell Therapeutics
Celgene
NPS Pharmaceuticals
Aegerion
Roche
Biogen Idec
Ariad Pharmaceuticals
Alexza
Navidea
Aveo
Arena's Marketing Partner Eisai Pharma Seeks Expedited Final Ruling From DEA To Begin Belviq Sales
Seeking Alpha
Mon, 12/24/12 - 10:37 am
Arena
Eisai
Belviq
Eisai Insurer Balks At Paying Whistleblower Claim
Pharmalot
Mon, 11/26/12 - 12:07 pm
Eisai
whistleblower lawsuits
This Week in Biotech: Part 2
Motley Fool
Sun, 11/11/12 - 09:19 am
Biocryst
Catalyst Pharmaceutical Partners
Pluristem Therapeutics
Vivus
Arena Pharmaceuticals
Eisai
FDA approves Eisai's drug to treat epileptic seizures
Yahoo/Reuters
Tue, 10/23/12 - 09:19 am
FDA
Eisai
epilepsy
seizures
Fycompa
3 Reasons Why Eisai Should Purchase Arena Pharmaceuticals
Motley Fool
Wed, 10/17/12 - 11:51 am
Arena Pharmaceuticals
Eisai
Belviq
Eisai’s Epilepsy Drug Helps Obese Patients Reduce Weight
Bloomberg
Wed, 10/17/12 - 11:20 am
Eisai
epilepsy
obesity
Zonegran
Is Alzheimer's Research the Next Big Thing in Biotech?
Motley Fool
Thu, 10/11/12 - 10:47 am
Alzheimer's disease
Eisai
Forest Labs
JNJ
Pfizer
Eli Lilly
Roche
Vivus Launches Qsymia - What To Look For Now
Seeking Alpha
Tue, 09/18/12 - 11:28 am
Vivus
Qsymia
Arena Pharmaceuticals
Eisai
Heroes And Zeros: Arena Pharmaceuticals And Avanir Pharmaceuticals
Seeking Alpha
Mon, 09/17/12 - 10:53 am
Arena Pharmaceuticals
Avanir
Eisai
Should Arena Hold Off On New Marketing And Supply Agreements?
Seeking Alpha
Thu, 08/23/12 - 09:59 am
Belviq
Arena Pharmaceuticals
Eisai
Eisai CEO Sees 'Huge' Medical Need for New Diet Drug
WSJ Online
Wed, 08/15/12 - 11:15 am
Eisai
obesity
Haruo Naito
Belviq
Arena Pharmaceuticals
Arena Pharmaceuticals transfers diet pill marketing rights to Japanese partner Eisai
Yahoo/AP
Mon, 07/30/12 - 12:23 pm
Belviq
Arena Pharmaceuticals
Eisai
Partnership and Acquisition in the Red Hot Weight Loss Market
Motley Fool
Mon, 07/16/12 - 08:45 am
Vivus
Arena Pharmaceuticals
obesity
M&A
Qnexa
Belviq
Pfizer
JNJ
Eisai
Eisai's Halavan misses endpoints in Phase III trial
Pharma Times, UK
Wed, 07/11/12 - 10:06 am
Eisai
Halavan
Xeloda
breast cancer
Pages
« first
‹ previous
…
14
15
16
17
18
19
20
21
22
next ›
last »